260 related articles for article (PubMed ID: 26335442)
1. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
[TBL] [Abstract][Full Text] [Related]
2. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
4. Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes.
Trinh NT; Privé A; Kheir L; Bourret JC; Hijazi T; Amraei MG; Noël J; Brochiero E
Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L870-82. PubMed ID: 17631610
[TBL] [Abstract][Full Text] [Related]
5. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
7. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
8. KCa3.1 modulates neuroblast migration along the rostral migratory stream (RMS) in vivo.
Turner KL; Sontheimer H
Cereb Cortex; 2014 Sep; 24(9):2388-400. PubMed ID: 23585521
[TBL] [Abstract][Full Text] [Related]
9. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
10. K
Robles-Martínez L; Garay E; Martel-Gallegos MG; Cisneros-Mejorado A; Pérez-Montiel D; Lara A; Arellano RO
Sci Rep; 2017 Jun; 7(1):4340. PubMed ID: 28659615
[TBL] [Abstract][Full Text] [Related]
11. Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis.
Faouzi M; Hague F; Geerts D; Ay AS; Potier-Cartereau M; Ahidouch A; Ouadid-Ahidouch H
Oncotarget; 2016 Jun; 7(24):36419-36435. PubMed ID: 27183905
[TBL] [Abstract][Full Text] [Related]
12. Ion channels in control of pancreatic stellate cell migration.
Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
[TBL] [Abstract][Full Text] [Related]
13. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
14. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.
Klein H; Garneau L; Trinh NT; Privé A; Dionne F; Goupil E; Thuringer D; Parent L; Brochiero E; Sauvé R
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C285-95. PubMed ID: 19052260
[TBL] [Abstract][Full Text] [Related]
17. Soluble and insoluble fibronectin increases alveolar epithelial wound healing in vitro.
Garat C; Kheradmand F; Albertine KH; Folkesson HG; Matthay MA
Am J Physiol; 1996 Nov; 271(5 Pt 1):L844-53. PubMed ID: 8944729
[TBL] [Abstract][Full Text] [Related]
18. Integrin mediation of alveolar epithelial cell migration on fibronectin and type I collagen.
Kim HJ; Henke CA; Savik SK; Ingbar DH
Am J Physiol; 1997 Jul; 273(1 Pt 1):L134-41. PubMed ID: 9252550
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
20. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
